Immunovant, Inc. (IMVT)

Immunovant Balance Sheet

Financials in millions USD. Fiscal year is April - March.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Cash & Equivalents	374.69	635.37	376.53	493.82	400.15	100.57
Cash & Short-Term Investments	374.69	635.37	376.53	493.82	400.15	100.57
Cash Growth	-45.77%	68.74%	-23.75%	23.41%	297.87%	1339.81%
Accounts Receivable	2.22	5.34	0.7	12.23	0.6	-
Other Receivables	-	0.17	0.19	0.63	0.55	3.05
Receivables	2.22	5.5	0.89	12.86	1.14	3.05
Prepaid Expenses	35.63	24.9	26.92	6.25	7.72	5.46
Total Current Assets	412.54	665.77	404.33	512.93	409.01	109.08
Property, Plant & Equipment	0.77	0.6	1.51	2.63	3.48	0.07
Long-Term Deferred Charges	-	-	-	-	-	0.25
Total Assets	420.93	666.37	405.84	515.56	412.49	109.39
Accounts Payable	19.82	7.16	1.35	18.63	2.43	1.19
Accrued Expenses	48.48	41.3	40.42	24.58	15.16	10.94
Short-Term Debt	-	-	-	-	-	3.19
Current Portion of Leases	0.02	0.14	1.17	1.15	1.18	-
Other Current Liabilities	-	0.02	0.35	0.17	-	-
Total Current Liabilities	68.32	48.61	43.3	44.52	18.77	15.32
Long-Term Leases	-	-	0.05	1.22	2.24	-
Total Liabilities	68.32	48.61	43.34	45.74	21.01	15.32
Common Stock	0.01	0.01	0.01	0.01	0.01	0.01
Additional Paid-In Capital	1,483	1,442	927.98	824.8	590.43	185.31
Retained Earnings	-1,133	-825.68	-566.35	-355.39	-198.66	-91.23
Comprehensive Income & Other	2.48	1.91	0.85	0.4	-0.3	-0.02
Shareholders' Equity	352.62	617.76	362.49	469.83	391.48	94.07
Total Liabilities & Equity	420.93	666.37	405.84	515.56	412.49	109.39
Total Debt	0.02	0.14	1.22	2.36	3.42	3.19
Net Cash (Debt)	374.66	635.23	375.31	491.45	396.73	97.38
Net Cash Growth	-45.75%	69.25%	-23.63%	23.88%	307.40%	1294.14%
Net Cash Per Share	2.56	4.60	3.05	4.48	4.52	2.25
Filing Date Shares Outstanding	169.86	146.05	130.41	116.51	97.98	80.91
Total Common Shares Outstanding	147.2	145.58	130.33	116.48	97.97	54.66
Working Capital	344.23	617.16	361.04	468.41	390.24	93.76
Book Value Per Share	2.40	4.24	2.78	4.03	4.00	1.72
Tangible Book Value	352.62	617.76	362.49	469.83	391.48	94.07
Tangible Book Value Per Share	2.40	4.24	2.78	4.03	4.00	1.72

Updated Feb 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q